Drugs used in Diabetes
Drugs used in Diabetes Companies (8)
Drugs used in Diabetes News
-
News This week in GLP-1 drug headlines: Manufacturing investment and new market launches
As drugmakers race to put their own GLP-1 drug products forward as the next biggest thing in weight-loss, current products are making numerous headlines this week with a number of new developments in their commercialisation and approval. Discover the l... -
News Gerresheimer predicts weight-loss drug deals to account for 4% of yearly growth
Dietmar Siemssen, CEO of German primary packaging manufacturer Gerresheimer, states that approximately 4% of the company’s revenue growth each year to come from deals with drugmakers of weight loss and diabetes products, particularly GLP-1 class ... -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Roche breaks into the obesity drug market with the acquisition of Carmot Therapeutics
In a bid to diversify their therapeutic offerings, Roche takes over Carmot Therapeutics in $2.7 billion deal, with one obesity drug spearheading the venture into the field as they prep for a Phase II in-human trial.
Drugs used in Diabetes Products (16)
-
Product GlycoX SAVIXOR®
Maintain optimal health with our Balanced Blood Glucose Support, specially formulated for both adults and children. Our comprehensive supplement is designed to promote stable blood sugar levels, ensuring energy balance and overall well-being.
Key Benefits: • Supports Healthy Blood Sugar Levels: ... -
Product Empagliflozin
Its used to treat type 2 diabetes, works in the kidneys to prevent absorption of glucose (blood sugar) also helps lower the blood sugar level. -
Product INSULIN Hmix , HbioR , NPH 100 IU
Insulin is human insulin with both a fast-acting and a long-acting effect. Insulin H Mix is used to reduce the high blood sugar level in patients with diabetes mellitus (diabetes). Diabetes is a disease where your body does not produce enough insulin to control the level of your blood sugar. Tre... -
Product Metformin PR tablets
Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. -
Product Dapagliflozin and combination tablets, Sitagliptin & Combination , Ticagrelor Tablet , Empagliflozin Tablet
Dapagliflozin 5/10 mg, Dapagliflozin Metformin IR 5/850 & 5/1000 mg, Dapagliflozin Metformin ER 2.5/1000, 5/500, 5/1000,10/500 & 10/1000 mg Sitagliptin Tablet 25/50/100mg Sitagliptin + Metformin Tablet Empagliflozin Tablet 10mg, 25mg -
Product ENVLO®
Envlo (Enavogliflozin) is a best-in-class SGLT2 inhibitor for T2DM.
Highlights of Envlo are:
* Launched in Korea from May 2023
* Approved by Korea MFDS in 2022 for T2DM
* T2DM Phase III was completed in Korea as a monotherapy and in combinations with other anti-diabetics (du... -
Product Sugarlo/Sugarlo Plus
Sugarlo tablets: Vildagliptin 50 mg Sugarlo Plus Film-Coated Tablets: Vildagliptin/metformin 50/500, 50/850, 50/1000 -
Product Ipragliflozin
a selective sodium glucose cotransporter 2 (SGLT2) inhibitor, is used for the treatment of type 2 diabetes mellitus -
Product DAPAJAY
Dapajay is a composition of (Dapagliflozin) which is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of d... -
Product Dapagliflozin propanediol hydrate + Sitagliptin (Tablet)
1. Active Ingredient & Strength : Dapagliflozin propanediol hydrate + Sitagliptin 100 mg/10 mg 2. Indication : Diabetes 3. Characteristics : - Simplification of 5GLT + DPP-4 co-administration - Small tablet size 4. Development Status : BE test completed -
Product Experimental Pharmacology - Development of pharmacological models
APIGENEX s.r.o. Offers a wide range of products which includes development of pharmacological models. Feature: it can be developed on the basis of the most up-to-date research. We are experienced in many pharmacological techniques including animal handling, various routes of administration, blood and tissu... -
Product ATB-101
[ARB+SGLT-2i Fixed Dose Combination] – In process of Phase 3 clinical trial on approx. 250 patients
1. The first Fixed Dose Combination treating hypertension and type 2 diabetes by a tablet in the world
2. Expect the synergistic effect in the treatment of hypertension though mi...
Upcoming Events
-
CPHI South East Asia 2024
Queen Sirikit National Convention Center, Bangkok, Thailand
10 Jul 2024 - 12 Jul 2024 -
CPHI Korea 2024
COEX, Seoul, Korea
27 Aug 2024 - 29 Aug 2024 -
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Pharmaceutical Industry Webinars
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance